BlueSphere Bio Data to be Presented at the 2022 Joint ASTCT
PITTSBURGH, May 25, 2022 (GLOBE NEWSWIRE) -- BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform...
Source: globenewswire.com
Stay updated with breaking news from Sawa Ito. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PITTSBURGH, May 25, 2022 (GLOBE NEWSWIRE) -- BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform...
PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) -- BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a revolutionary TCR discovery...